Jaguar Health (JAGX) EBITDA Margin Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 9,942.00 |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 530.00 |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -1,211.00 |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 6,959.00 |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 6,993.00 |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.19 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | 8,109.00 |
| Jun 30, 2025 | -4,697.00 |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | 28,783.00 |
| Sep 30, 2024 | 131,578.00 |
| Jun 30, 2024 | 279,091.00 |
| Mar 31, 2024 | 37,624.00 |
| Dec 31, 2023 | -12,798.00 |
| Sep 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 6.01 Mn |
| Mar 31, 2023 | -2.10 Mn |
| Dec 31, 2022 | -1.93 Mn |
| Sep 30, 2022 | 37,550.00 |
| Jun 30, 2022 | 40,082.00 |
| Mar 31, 2022 | -5.84 Mn |
| Dec 31, 2021 | 23,857.00 |
| Sep 30, 2021 | -97,471.00 |
| Jun 30, 2021 | -225,447.00 |